Zhou et al. revealed that Notch4 overexpression can promote the EMT of breast cancer cells and maintain the self-renewal properties of mesenchymal breast cancer stem cells [38], which is of concern and is associated with endocrine drug resistance in breast cancer. The gene discussed is NOTCH4; the disease is breast carcinoma.